Gaspar Bobby

Chief Executive Officer, DirectorOrchard Therapeutics plc (ORTX) · full profile →Form 4 · filed Oct 6, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 4, 2022Grant(A)55K$055K
Oct 4, 2022Disposed to issuer(D)55K$00
Oct 4, 2022Grant(A)850K$0850K
Oct 4, 2022Disposed to issuer(D)850K$00
Oct 4, 2022Disposed to issuer(D)50K$00
Oct 4, 2022Disposed to issuer(D)300K$00
Oct 4, 2022Grant(A)200K$0200K
Oct 4, 2022Disposed to issuer(D)200K$00
Oct 4, 2022Grant(A)50K$050K
Oct 4, 2022Grant(A)300K$0300K

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-053004) within minutes of acceptance. Every field above traces to the original document. Verify it directly: